B-cell lymphomas represent a heterogeneous group of neoplasms originating from B lymphocytes, with variable clinical behaviour and prognostic outcomes. Extranodal involvement occurs when these ...

Phase I Study of BMS-214662, a Farnesyl Transferase Inhibitor in Patients With Acute Leukemias and High-Risk Myelodysplastic Syndromes Sites of the disease were: lymph node, 222 cases (58%); ...

Please provide your email address to receive an email when new articles are posted on . In this video, Leo I. Gordon, MD, FACP, discusses highlights from his presentation on extranodal marginal zone ...

Non-Hodgkin lymphoma outcomes are linked to hemoglobin, LDH, ECOG scores, and disease stage, with extranodal cases needing more research. Extranodal NHL in head and neck regions is under-researched, ...

Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall: Radiation Therapy Oncology Group ...

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive malignancy most frequently involving the nasal cavity and upper aerodigestive tract, although it may present in other extranodal ...

A very unusual case of lip-based diffuse large B-cell lymphoma (DLBCL) was treated successfully thanks to prompt diagnosis and chemotherapy treatments. Upon seeing a lip lesion, a physician’s first ...

A 10-year follow-up confirms the potential role of doxycycline in treating conjunctival lymphoma associated with urogenital chlamydia.

Breyanzi showed significant efficacy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma, achieving primary and secondary endpoints in the TRANSCEND FL trial. Marginal zone lymphoma, a slow ...

Abdominal/gastrointestinal complaints are the most prevalent initial symptoms in DLBCL, reported by 26% of patients. Peripheral lymphadenopathy and testicular tumors are associated with low-risk ...